This page shows the latest EU news and features for those working in and with pharma, biotech and healthcare.
Moderna has completed regulatory submissions for mRNA-1273.214 in the EU, Australia and Canada and anticipates further authorisations over the next few weeks.
The drug is currently approved in more than 70 markets around the world, including the US, EU Japan and China, to treat adults with non-metastatic castration-resistant prostate cancer (nmCRPC)
The drug was approved in the US in November 2019 and is also approved in the EU, the UAE, Oman and Britain.
The treatment is also approved in major markets outside the US, including the EU and Japan.
Through this agreement for 85 million doses, we can help the EU and European countries, as well as other countries and regions, be better prepared for future pandemics.”. ... officially declared by the World Health Organization (WHO) or the EU.
patients in the EU.”.
More from news
Approximately 143 fully matching, plus 2,311 partially matching documents found.
In Japan this is already the case, but EU and US regulators are yet to approve the move to digital instructions.
Our research was conducted over several weeks in 2020 with over 2, 000 healthcare professionals across a wide range of therapy areas in the US and EU Big Five, as well
Investigating the EU regulatory hurdles that life sciences companies face as they seek to improve patient access to biosimilar therapy. ... By the end of 2020, it was estimated that biosimilars had saved the EU up to $44bn in healthcare costs.
accessible information is established, to navigate the cross- border healthcare framework for all stakeholders (ie, a dedicated EU website). ... The development of Commission guidelines that set harmonised review and approval timelines that will expedite
For example, there are 30 million people in the EU who live with a rare disease, for whom the perceived lack of prioritisation is stark.
More from intelligence
Approximately 9 fully matching, plus 202 partially matching documents found.
awards, including Cannes Lions Healthcare Agency of the Year, PMEA EU Healthcare Agency of the Year and Creative Floor Most Awarded Agency.
Benjamin Rapp, regional president EU South at Ashfield Engage.
I look forward to working with the EFPIA Board and the wider community to achieve the shared goal of building a future EU health and innovation union.”. ... Realising that goal means EFPIA and its membership working with the EU and Member States to
Lugović joins from GOPA Com. Brussels, where she ran global campaigns for the European Commission across the EU, US, Africa and Asia. ... Prior to that, she headed the regional representation of South Serbia to the EU for a period of six years.
He added: “Over the coming months, my colleagues and I look forward to engaging with the EU Institutions and across Member States to discuss how we can work together to ensure ... that the EU remains an innovation leader and to build a healthier future
More from appointments
Approximately 2 fully matching, plus 67 partially matching documents found.
Therapy Watch Lupus patient data is collected from a panel of 600 physicians across the main 5 EU markets, China, Japan, and the US.
Bassil Akra, CEO of AKRA TEAM GmbH, takes a deep dive into the new approval process for medical devices in the EU and shares how his company is supporting Medical Device ... and In Vitro Diagnostic companies to get safe, qualitative, and well-performing
With the EU’s upcoming revision of the general pharmaceutical legislation, the bloc has the chance to provide long-awaited clarity around the future of nanomedicine. ... of its proposal on the update of EU pharmaceutical legislation by the end of 2022.
Pharmaceutical companies know doctors want high-value educational content. In a highly pressurised, cost-constrained healthcare environment with increasing demands for value and improved patient outcomes, time-poor doctors are calling out for more
Embedding a digital strategy as a prominent part of a pharmaceutical marketing campaign is becoming ever more important. Despite some perceived reluctance on the part of the industry, pharmaceutical companies are now exploring and exploiting a
More from PMHub
Approximately 4 fully matching, plus 147 partially matching documents found.
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...